Cabrini Research Grants

Targeting projects to improve patient outcomes

Since 2015, Cabrini has overseen an annual grant funding round to support small- to medium-scale projects capable of delivering tangible benefits to our patients. Made possible by our donors, this funding allows researchers to accelerate progress and make clinically meaningful contributions to healthcare.

Each year, two funding streams are made available to Cabrini researchers through the Auric Innovation Grant and the Cabrini Foundation Grant. These are administered through a centralised evaluation process involving members from our Executive Leadership Team, Consumer and Community Involvement Committee, and professional services.

For more information on these grant funding opportunities and how to support them, contact the Cabrini Foundation at foundation@cabrini.com.au.

Cabrini Foundation Grants

Facilitated by contributions to the Cabrini Foundation designated for research, these grants support targeted projects providing funding up to $30 000. Since their introduction, they have proven pivotal for researchers to pursue smaller-scale projects of immediate impact, or in enabling intermediary milestones that contribute to broader research goals.

Auric Innovation Grants

The Auric Innovation Grant funds projects that have the potential to eventually change medical perspectives and approaches. Supported by the continued philanthropy of Mr Brian and Mrs Lee Johnstone, the Grant provides up to $200 000 for researchers to implement scientific and clinical innovations into practice.

 

Year Recipient Project
2023 Dr Rebekah Engel, Cabrini Monash University Department of Surgery To develop a predictive platform for colorectal cancer recurrence, applying artificial intelligence tools for high-throughput screening of patient-derived tissue biobanks.
2022 Professor Gary Richardson OAM, Cabrini Monash University Department of Medical Oncology To create a precision oncology platform for patients with metastatic breast cancer with preclinical models that predict the effectiveness and adverse-side effects of therapies before administration.
2021 Josh Farrington, Cabrini Technology Group To develop a software platform (eCaptis) that digitally captures and reports patient-reported outcome measures through standardised questionnaires concerning their symptoms and functionality.
2020 Professor Gary Richardson OAM, Cabrini Monash University Department of Medical Oncology To establish an academic exercise physiology program at the Cabrini Cancer Institute, evaluating the benefits of exercise for patient outcomes and quality-of-life.
2019 Dr Gabriel Blecher, Cabrini Emergency Department To manage acute behavioural disturbances for elderly emergency department patients, developing customised distraction techniques with multiple audio-visual media techniques.
2019 Sharni Clark, Ashwood Residential Aged Care To establish a living lab in aged care, implementing design innovations that improve the lived experience of residents, families, and staff at Ashwood Residential Aged Care.